370 related articles for article (PubMed ID: 19120089)
1. From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases.
Taché Y; Brunnhuber S
Ann N Y Acad Sci; 2008 Dec; 1148():29-41. PubMed ID: 19120089
[TBL] [Abstract][Full Text] [Related]
2. CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.
Taché Y; Martinez V; Wang L; Million M
Br J Pharmacol; 2004 Apr; 141(8):1321-30. PubMed ID: 15100165
[TBL] [Abstract][Full Text] [Related]
3. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
Martinez V; Taché Y
Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
Nozu T; Okumura T
J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.
Lv Y; Wen J; Fang Y; Zhang H; Zhang J
Peptides; 2022 Jan; 147():170705. PubMed ID: 34822913
[TBL] [Abstract][Full Text] [Related]
6. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors.
O'Malley D; Dinan TG; Cryan JF
Peptides; 2010 Apr; 31(4):662-70. PubMed ID: 20096320
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor and the brain-gut motor response to stress.
Taché Y; Martinez V; Million M; Rivier J
Can J Gastroenterol; 1999 Mar; 13 Suppl A():18A-25A. PubMed ID: 10202204
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Corticotropin Releasing Factor Signaling Inhibits Gastric Emptying: Mechanisms of Action and Role in Stress-related Gastric Alterations of Motor Function.
Czimmer J; Tache Y
Curr Pharm Des; 2017; 23(27):4042-4047. PubMed ID: 28245760
[TBL] [Abstract][Full Text] [Related]
9. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
10. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
Taché Y; Martinez V; Million M; Maillot C
Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Gastroenterol; 2017 Jan; 52(1):72-80. PubMed ID: 27075754
[TBL] [Abstract][Full Text] [Related]
12. Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.
Tache Y; Larauche M; Yuan PQ; Million M
Curr Mol Pharmacol; 2018; 11(1):51-71. PubMed ID: 28240194
[TBL] [Abstract][Full Text] [Related]
13. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents.
Taché Y; Million M; Nelson AG; Lamy C; Wang L
Gend Med; 2005 Sep; 2(3):146-54. PubMed ID: 16290887
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.
Larauche M; Kiank C; Tache Y
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7(Suppl 7):33-46. PubMed ID: 20388944
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.
Hauger RL; Risbrough V; Brauns O; Dautzenberg FM
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):453-79. PubMed ID: 16918397
[TBL] [Abstract][Full Text] [Related]
16. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
Maillot C; Million M; Wei JY; Gauthier A; Taché Y
Gastroenterology; 2000 Dec; 119(6):1569-79. PubMed ID: 11113078
[TBL] [Abstract][Full Text] [Related]
17. The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.
Million M; Zhao JF; Luckey A; Czimmer J; Maynard GD; Kehne J; Hoffman DC; Taché Y
PLoS One; 2013; 8(9):e73749. PubMed ID: 24040053
[TBL] [Abstract][Full Text] [Related]
18. Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents.
Gourcerol G; Wu SV; Yuan PQ; Pham H; Miampamba M; Larauche M; Sanders P; Amano T; Mulak A; Im E; Pothoulakis C; Rivier J; Taché Y; Million M
Gastroenterology; 2011 May; 140(5):1586-96.e6. PubMed ID: 21277852
[TBL] [Abstract][Full Text] [Related]
19. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
[TBL] [Abstract][Full Text] [Related]
20. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.
Taché Y
Neurogastroenterol Motil; 2015 Jan; 27(1):1-6. PubMed ID: 25557223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
